Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Biotechnology companies can use “value-chain analysis” to create processes for maximizing the value of their intellectual property portfolios, say Bill Barrett and Dave Crawford.
Putting in place a sound strategy for protecting and maximizing a company's intellectual property can boost its future value, say Steven Meltzer, Michelle Marks, and James McCormick.
Founders, senior executives, and venture capitalists often own restricted equity in startup companies, which they must manage proactively to minimize the risk and maximize value, says C. Mark Tang.
